Gail D’Onofrio, MD, MS is the Albert E. Kent Professor of Emergency Medicine and was the Inaugural Chair of the Department of Emergency Medicine at the Yale School of Medicine (2009) and Physician-in Chief of Emergency Services at Yale New Haven Hospital EDs with an annual census of approximately 180,000 patients. She is also Professor in the School of Public Health in the Department of Chronic Disease Epidemiology and is boarded in emergency and addiction medicine.
Internationally known for her work in alcohol and other substance use disorders (SUDs) as well as her research on gender variations in women with ischemic heart disease, Dr. D’Onofrio has extensive experience as a leader, researcher, mentor and educator. Her work (JAMA, 2015) demonstrating that ED-initiated buprenorphine increases engagement in addiction treatment for individuals with OUD, has changed clinical practice, receiving multiple science awards, including awards from the Hazelden Betty Ford Foundation, the Clinical Research Forum and the R. Brinkley Smithers and Distinguished Scientist Award by the American Society of Addiction Medicine.
Dr. D’Onofrio has a long track record of mentoring physician scientists in independent research careers. She is the PI of a NIDA K12 establishing the Yale Drug Use, Addiction and HIV Research Scholars (Yale-DAHRS) program, a Mentored Career Development Program with focused training in prevention and treatment of drug use, addiction, and HIV in general medical settings with scholars in Medicine, Emergency Medicine (EM), Pediatrics, Obstetrics and Gynecology, and Pulmonary Critical Care; and she has mentored numerous EM faculty. She has received several awards which reflect her dedication to mentorship and nurturing careers of junior investigators, including Excellence in Mentoring award from the Association for Medical Education and Research in Substance Abuse (AMERSA 2008), Advancing Women in Emergency Medicine award from the Society of Academic Emergency Medicine (SAEM 2016) and the Academy for Women in Academic Emergency Medicine (AWAEM) Outstanding Department Award for the advancement of women (SAEM 2018).
Dr. D’Onofrio is a founding Board member of the Board of Addiction Medicine recently recognized by ABMS as a Specialty, Sub-specialty. An advocate for individuals with SUD, she is one of the architects of Connecticut Governor’s Strategic Plan to Reduce Opioid Deaths, working with multiple agencies regionally and nationally to change policies and introduce interventions to combat the opioid crisis. She was recently appointed to serve on the National Advisory Council on Drug Abuse for the National Institutes of Health.
In conjunction with her roles as Department Chair and Professor, Dr. D’Onofrio is also an independent NIH-funded physician-scientist with over two decades of experience designing and implementing clinical trials in the ED setting related to alcohol and drug use, specifically, the initiation of buprenorphine for opioid use disorder. She is a Lead Investigator on a NIDA Clinical Trials Network (CTN) multi-site study, “Implementation of ED-Initiated Buprenorphine for Opioid Use Disorder.”
|Distinguished Alumni Award||Boston University||2022|
|Distinguished Service Award||Association of Academic Chairs of Emergency Medicine||2022|